Rena Therapeutics Inc.
PrivateLast Round
M&A
Nov 21, 2019
Est. Valuation
$16.62M
Total Funding Raised
$10.36M
Company Overview
Rena Therapeutics Inc. is a biotechnology company that develops Heteroduplex Oligonucleotide (HDO) technology as a platform for nucleic acid medicine drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rena Therapeutics Inc. Comparables
Compare Rena Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liid Pharmaceuticals, Inc. | 81% | |
| Bonac Corporation | 73% | |
| NapaJen Pharma, Inc. | 72% |
Rena Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 21, 2019 | ||||
| Series B | Jun 30, 2017 | ||||
| Series A | Apr 20, 2015 |
Rena Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Network Corporation of Japan | Series A, Series B |
| DBJ Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2025
Monthly visitors grew 38% MoM, reaching 1.8K.
Rena Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rena Therapeutics Inc.'s valuation, stock price, and market status.
Is Rena Therapeutics Inc. a public or private company?
Rena Therapeutics Inc. is a private company.
What is the current stock price of Rena Therapeutics Inc.?
Rena Therapeutics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Rena Therapeutics Inc. worth (valuation)?
Rena Therapeutics Inc.'s valuation is estimated at $16.6M based on funding round data.
Can I buy Rena Therapeutics Inc. stock?
Rena Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rena Therapeutics Inc.'s last funding round?
Rena Therapeutics Inc.'s most recent funding round was M&A on June 30, 2017.
Who are the main investors in Rena Therapeutics Inc.?
Key investors in Rena Therapeutics Inc. include Innovation Network Corporation of Japan, DBJ Capital.
Will Rena Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Rena Therapeutics Inc..
How can I track Rena Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rena Therapeutics Inc.'s secondary market activity and sign up for updates.